2851SPhosphoSerThr ATMATR Substrate Antibody and 1 more item

Virginia Commonwealth University (VCU) awarded a contract to Cell Signaling Technology on August 4, 2026, for the procurement of specialized antibody reagents. The contract, identified as A236_P0346108, carries a cumulative value of $519 and covers two distinct line items to be delivered to VCU Procurement in Virginia. The first line item consists of one unit of phosphoSerThr ATMATR Substrate Antibody priced at $374, while the second line item comprises one unit of Glut4 1F8 Mouse Monoclonal Antibody priced at $145.35.

The contract represents a straightforward transactional purchase of research-grade antibody products for use by Virginia Commonwealth University. These antibodies are scientific reagents commonly utilized in cellular and molecular biology research applications. No specific contract period of performance or annual value information is provided in the available documentation beyond the cumulative total of $519. The procurement was executed through VCU's contracting organization, with Cell Signaling Technology serving as the prime contractor supplying the requested materials to support the institution's research operations.